{"title": "2021's top 10 clinical trial flops", "author": "Phil Taylor", "url": "https://www.fiercebiotech.com/special-reports/2021s-top-10-clinical-trial-flops", "hostname": "fiercebiotech.com", "description": "Drug development always comes with a high risk of things going awry. One commonly quoted statistic is 90% of programs fail during the clinical trial phase, mainly because of a lack of clinical efficacy. Thousands of studies are registered each year in the U.S. alone, so every year there is a vast array of disappointing results to choose from as we compile this list. To narrow down the field, we sift through the casualties to identify the failures that had a material impact. | Thousands of studies are registered each year in the U.S. alone, so there is always a vast array of disappointing results to choose from as we compile our top 10 clinical trial flops.", "sitename": "FierceBiotech", "date": "2022-03-01", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}